Alzheimer Disease Clinical Trials in Raleigh, North Carolina
2 recruitingRaleigh, North Carolina
Showing 1–2 of 2 trials
Recruiting
Phase 2
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Alzheimer DiseaseAgitation
Celgene120 enrolled52 locationsNCT06808984
Recruiting
Late Onset Alzheimer's Disease
Alzheimer Disease
Columbia University10,000 enrolled12 locationsNCT05010603